Ingrid Hedenfalk
61 – 70 of 93
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
High proliferation is associated with inferior Outcome in male breast cancer patients
(
- Contribution to journal › Article
-
Mark
Requirement of Apoptotic Protease-Activating Factor-1 for Bortezomib-Induced Apoptosis but Not for Fas-Mediated Apoptosis in Human Leukemic Cells
(
- Contribution to journal › Article
-
Mark
Cancerforskning vid Lunds universitet: En rapport avseende forskning inom Regionalt Cancercentrum Syd
2013)(
- Book/Report › Report
- 2012
-
Mark
Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancer.
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
(
- Contribution to journal › Article
-
Mark
Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis.
(
- Contribution to journal › Article
-
Mark
Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.
(
- Contribution to journal › Article
- 2011
-
Mark
Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden)
(
- Contribution to journal › Article
-
Mark
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer
(
- Contribution to journal › Article